Cargando…

ZBP1 inflames the SARS-CoV-2-infected lung

Detalles Bibliográficos
Autores principales:	Yin, Chaoran, Balachandran, Siddharth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Nature Singapore 2023
Materias:	Research Highlight
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9930697/ https://www.ncbi.nlm.nih.gov/pubmed/36792808 http://dx.doi.org/10.1038/s41422-023-00784-5

Ejemplares similares

ZBP1 contributes to interferonopathies caused by impaired ADAR1 function
por: Fang, Xiuwu, et al.
Publicado: (2022)

Autoimmunity and SARS‐CoV‐2 infection: Unraveling the link in neurological disorders
por: Latorre, Daniela
Publicado: (2022)

Cellular basis for SARS-CoV-2 infection
por: Baumann, Kim
Publicado: (2020)

Janus kinase signaling as risk factor and therapeutic target for severe SARS‐CoV‐2 infection
por: Solimani, Farzan, et al.
Publicado: (2021)

A promiscuous interaction of SARS-CoV-2 with bacterial products
por: Carissimo, Guillaume, et al.
Publicado: (2020)

Virtual Issue on SARS-CoV-2: Evolution of a Pandemic
por: McGrath, Casey
Publicado: (2023)

Kidney injury molecule-1: a novel entry factor for SARS-CoV-2
por: Wan, Cheng, et al.
Publicado: (2021)

A two‐step infection model: From SARS‐CoV‐2 entry and trafficking to egress and spread
por: You, Liting, et al.
Publicado: (2023)

How will previous infection or current vaccination strategies protect us from future SARS‐CoV‐2 variant infections?
por: Monteiro, Olivia
Publicado: (2022)

Organoids demonstrate gut infection by SARS-CoV-2
por: Dickson, Iain
Publicado: (2020)

Effects of pancreatic SARS-CoV-2 infection identified
por: Morris, Alan
Publicado: (2021)

Antigen‐dependent multistep differentiation of T follicular helper cells and its role in SARS‐CoV‐2 infection and vaccination
por: Baumjohann, Dirk, et al.
Publicado: (2021)

Opsonizing antibodies mediated SARS‐CoV‐2 entry into monocytes leads to inflammation
por: Yao, Tong, et al.
Publicado: (2022)

The SARS-CoV-2 spike protein: balancing stability and infectivity
por: Berger, Imre, et al.
Publicado: (2020)

Profiling and characterization of SARS-CoV-2 mutants’ infectivity and antigenicity
por: Wang, Lin, et al.
Publicado: (2020)

AngII autoantibodies after SARS-CoV-2 infection
por: Wang, Monica
Publicado: (2022)

Potential recombination between SARS-CoV-2 and MERS-CoV: calls for the development of Pan-CoV vaccines
por: Wang, Qiao, et al.
Publicado: (2023)

SARS-CoV-2 sensory loss
por: York, Ashley
Publicado: (2022)

Sewer biofilms and SARS-CoV-2
por: Du Toit, Andrea
Publicado: (2023)

SURFing SARS-CoV-2 inhibition
por: Taglialegna, Agustina
Publicado: (2023)

Double insult: flu bug enhances SARS-CoV-2 infectivity
por: Su, Shan, et al.
Publicado: (2021)

SARS-CoV-2 vaccines: anamnestic response in previously infected recipients
por: Purushotham, Jyothi N., et al.
Publicado: (2021)

SARS-CoV-2 infection of monocytes: balancing acts of antibodies and inflammasomes
por: Brewer, R. Camille, et al.
Publicado: (2022)

SARS-CoV-2 nanobodies 2.0
por: Labroussaa, Fabien, et al.
Publicado: (2021)

Novel SARS-CoV-2 receptors: ASGR1 and KREMEN1
por: Hoffmann, Markus, et al.
Publicado: (2021)

SARS-CoV-2-induced lung pathology: AHR as a candidate therapeutic target
por: Giovannoni, Federico, et al.
Publicado: (2020)

A CNS gateway for SARS-CoV-2
por: Yates, Darran
Publicado: (2021)

SARS-CoV-2 detected in olfactory neurons
por: Lemprière, Sarah
Publicado: (2021)

Super(antigen) target for SARS-CoV-2
por: Brown, Matthew, et al.
Publicado: (2021)

Timing vaccination against SARS-CoV-2
por: Barnoud, Coline, et al.
Publicado: (2021)

Effects of mutations on SARS-CoV-2 fitness
por: Chirigati, Fernando
Publicado: (2022)

SARS-CoV-2 rewires host chromatin
por: Du Toit, Andrea
Publicado: (2023)

Landscapes of SARS-CoV-2-reactive CD8(+) T cells: heterogeneity of host immune responses against SARS-CoV-2
por: Koh, June-Young, et al.
Publicado: (2021)

A booster with SARS-CoV-2 vaccines: protection against Omicron infection
por: Hu, Yuehong, et al.
Publicado: (2022)

FXR inhibition: an innovative prophylactic strategy against SARS-CoV-2 infection
por: Li, Zhe, et al.
Publicado: (2023)

SARS-CoV-2 infection of kidney organoids prevented with soluble human ACE2
por: Allison, Susan J.
Publicado: (2020)

Not only ACE2—the quest for additional host cell mediators of SARS-CoV-2 infection: Neuropilin-1 (NRP1) as a novel SARS-CoV-2 host cell entry mediator implicated in COVID-19
por: Kyrou, Ioannis, et al.
Publicado: (2021)

Type I interferon signaling deficiency results in dysregulated innate immune responses to SARS‐CoV‐2 in mice
por: Ogger, Patricia P., et al.
Publicado: (2022)

Circular RNA vaccine, a novel mRNA vaccine design strategy for SARS‐CoV‐2 and variants
por: Su, Peng, et al.
Publicado: (2022)

SARS-CoV-2: the many pros of targeting PLpro
por: McClain, Christopher B., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ipbkfbqcf0b1ola82jdsvl34kj